Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for GLGI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
February 28, 2026 -80.72%
November 30, 2025 -26.57%
August 31, 2025 -10.24%
May 31, 2025 6.99%
February 28, 2025 6.75%
November 30, 2024 -1.69%
August 31, 2024 2.49%
May 31, 2024 13.66%
February 29, 2024 2.13%
November 30, 2023 6.19%
August 31, 2023 10.02%
May 31, 2023 9.34%
February 28, 2023 27.22%
November 30, 2022 -1.55%
August 31, 2022 7.25%
May 31, 2022 4.98%
February 28, 2022 2.69%
November 30, 2021 -1.45%
August 31, 2021 21.13%
May 31, 2021 4.68%
February 28, 2021 5.39%
November 30, 2020 6.59%
August 31, 2020 5.74%
May 31, 2020 10.41%
February 29, 2020 9.95%
Date Value
November 30, 2019 2.42%
August 31, 2019 3.32%
May 31, 2019 3.65%
February 28, 2019 1.34%
November 30, 2018 2.02%
August 31, 2018 4.20%
May 31, 2018 7.20%
February 28, 2018 0.05%
November 30, 2017 1.48%
August 31, 2017 5.16%
May 31, 2017 7.80%
February 28, 2017 10.59%
November 30, 2016 2.01%
August 31, 2016 0.34%
May 31, 2016 6.60%
February 29, 2016 -1.13%
November 30, 2015 2.65%
August 31, 2015 0.87%
May 31, 2015 6.71%
February 28, 2015 9.14%
November 30, 2014 -16.77%
August 31, 2014 5.81%
May 31, 2014 20.60%
February 28, 2014 -2.16%
November 30, 2013 -0.29%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Albemarle Corp. 28.64%
Core Molding Technologies, Inc. --
Eastman Chemical Co. 7.31%
Mativ Holdings, Inc. 0.64%
Westlake Corp. 8.25%